Fundraising Fox
Borea Therapeutics
Founded 2021 · 4 employees on LinkedIn · 1 known investors
Find your way into Borea Therapeutics
Sign up to see every warm intro you have to Borea Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Borea Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.
Founders & leadership
Borea Therapeutics was founded in 2021 by Paul Heppenstall.
PH
Paul HeppenstallScientific Co-Founder
NB
Investors · 1
Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Borea Therapeutics do?
- Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.
- Who founded Borea Therapeutics?
- Borea Therapeutics was founded by Paul Heppenstall in 2021.
- Who are Borea Therapeutics's investors?
- Borea Therapeutics's investors include Sofinnova Partners.